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Abstract
Background: In view of the close relationship of Portugal with African countries, particularly former Portuguese
colonies, the diagnosis of malaria is not a rare thing. When a traveller returns ill from endemic areas, malaria
should be the number one suspect. World Health Organization treatment guidelines recommend that adults with
severe malaria should be admitted to an intensive care unit (ICU).
Methods: Severe cases of malaria in patients admitted to an ICU were reviewed retrospectively (1990-2011) and
identification of variables associated with in-ICU mortality performed. Malaria prediction score (MPS), malaria score
for adults (MSA), simplified acute physiology score (SAPSII) and a score based on WHO’s malaria severe criteria
were applied. Statistical analysis was performed using StataV12.
Results: Fifty nine patients were included in the study, all but three were adults; 47 (79,6%) were male;
parasitaemia on admission, quantified in 48/59 (81.3%) patients, was equal or greater than 2% in 47 of them
(97.9%); the most common complications were thrombocytopaenia in 54 (91.5%) patients, associated with
disseminated intravascular coagulation (DIC) in seven (11.8%), renal failure in 31 (52.5%) patients, 18 of which
(30.5%) oliguric, shock in 29 (49.1%) patients, liver dysfunction in 27 (45.7%) patients, acidaemia in 23 (38.9%)
patients, cerebral dysfunction in 22 (37.2%) patients, 11 of whom with unrousable coma, pulmonary oedema/ARDS
in 22 (37.2%) patients, hypoglycaemia in 18 (30.5%) patients; 29 (49.1%) patients presented five or more
dysfunctions. The case fatality rate was 15.2%. Comparing the four scores, the SAPS II and the WHO score were the
most sensitive to death prediction. In the univariate analysis, death was associated with the SAPS II score, cerebral
malaria, acute renal and respiratory failure, DIC, spontaneous bleeding, acidosis and hypoglycaemia. Age, partial
immunity to malaria, delay in malaria diagnosis and the level of parasitaemia were not associated with death in
this cohort.
Conclusion: Severe malaria cases should be continued monitored in the ICUs. SAPS II and the WHO score are
good predictors of mortality in malaria patients, but other specific scores deserve to be studied prospectively.
Keywords: Plasmodium falciparum, Severe malaria, Prognosis, Shock, Multi-organic dysfunction, ARDS, ICU, Fatality
rate
Background
The number of malarial infections acquired by interna-
tional travellers, thought to be nearly 25,000 cases
annually, remains very small compared with the annual
global incidence of nearly 250 million malaria cases and
about 700,000 related deaths in endemic areas, mainly
among young children in Africa. Malaria in non-ende-
mic countries is a challenge since, due to the fact that it
is infrequent, experience in diagnosis and treatment is
scarce and delays in diagnosis and adequate treatment
may be fatal to the patient [1-3].
The diagnosis of malaria requires a high index of sus-
picion, as symptoms can mimic many other diseases.
Portugal maintains a close relationship with African
countries for several reasons and so malaria must be
suspected in travellers that return from those countries.
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people that were born and live in Africa travelling to
Portugal to visit friends and relatives, immigrants (peo-
ple that were born in an endemic area and that live in
Portugal) and those travelling for business or tourism.
Malaria is a notifiable disease in Portugal; about 50
cases are reported annually to the Public Health System,
but cases are under-reported [4]. The notification
implies filling-in a form that needs to be posted, which
leads to forgetfulness. A person from a non-endemic
country (emigrant or expatriate) who stays in malaria-
affected areas for less than two years is considered non-
immune, and also at greater risk of more severe forms
of the disease [5]. Non-immune people can develop
symptoms of falciparum malaria within a month after
leaving the endemic area (average 10 days) but, some-
times, after longer periods as can be observed in preg-
nant women, immigrants, people that were prescribed
mefloquine and HIV-infected people [6-8].
Severe forms of malaria are almost always caused by
Plasmodium falciparum; though rare, vivax malaria
can also cause severe disease. The object of this study
is falciparum malaria solely. Severe forms of malaria
should be regarded as a medical emergency and
managed in intensive care units (ICU) [9-11]. Clinical
deterioration usually develops three to seven days after
fever onset, but it can sometimes develop in the first
24 hours. A high standard of care and continued mon-
itoring in the acute stage is very important to reduce
mortality [12,13].
In 1990, the World Health Organization (WHO)
established the criteria for severe malaria which were
revised in 2010 (Table 1), with the purpose of identify-
ing individuals at risk of dying and specifying the risk
factors of severe forms of the disease. The guidelines for
the treatment of malaria published in 2006 were also
revised in 2010 [14-16].
In general, there is a correlation between the parasite
density in the peripheral blood and the severity of the
disease and its complications, especially among non-
immune people. In such cases, the patients’ clinical con-
dition can deteriorate even after initial appropriate treat-
ment due to exacerbation of systemic inflammatory
response, leading to organ dysfunction [17-19].
The aim of this retrospective study is to describe the
clinical spectrum of severe malaria cases admitted to an
ICU and identify factors associated with in-ICU
mortality.
Table 1 WHO criteria for severe malaria [10,15,17]
Manifestation Definition
Cerebral malaria Impaired consciousness or unrousable coma not attributable to any other cause, with a Glasgow
score ≤ 9.
Prostration, i.e. generalized weakness so that the patient is unable to walk, or sit up without
assistance
Failure to feed
Multiple convulsions - more than two episodes in 24 h
Severe
anaemia
Haematocrit < 15% or haemoglobin < 5 g/dl in the presence of parasite count > 10 000/μl
Renal failure Urine output < 400 ml/24 hours in adults (< 12 ml/kg/24 hours in children) and a serum creatinine
> 265 μmol/l (> 3.0 mg/dl) despite adequate volume repletion
Pulmonary oedema and ARDS The acute lung injury score is calculated on the basis of radiographic densities, severity of
hypoxemia, and positive end-expiratory pressure
Hypoglycaemia Whole blood glucose concentration
< 2.2 mmol/l (< 40 mg/dl)
Circulatory collapse Systolic blood pressure < 70 mmHg in patients > 5 years of age (< 50 mmHg in children aged 1-5),
with cold clammy skin or a core-skin temperature difference > 10°C
Abnormal bleeding and/or disseminated
intravascular coagulation
Spontaneous bleeding from gums, nose, gastrointestinal tract, or laboratory evidence of
disseminated intravascular coagulation
Repeated generalized seizures ≥2 seizures observed within 24 hours
Acidaemia/acidosis Arterial pH < 7.25 or acidosis (plasma bicarbonate < 15 mmol/l)
Macroscopic haemoglobinuria Haemolysis not secondary to glucose-6-phospha
e dehydrogenase deficiency
Impaired consciousnesss Rousable mental condition
Prostration or weakness Generalized weakness so that the patient is unable to walk
or sit up without assistance
Hyperparasitaemia > 2% parasitized erythrocytes or > 250 000 parasites/μl (in non-immune individuals)
Hyperpyrexia Core body temperature > 40°C
Hyperbilirubinaemia Total bilirubin > 43 μmol/l (> 2.5 mg/dl)
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Between January 1990 and May 2011, 284 patients suf-
fering from malaria were admitted to the Infectious Dis-
ease Service of University Hospital in Oporto, northern
Portugal. From this cohort, 59 severe malaria cases,
according to WHO criteria, were admitted to the ICU
of the Infectious Diseases Service (ICU-ID). Patients
charts were reviewed retrospectively as well as data on
demographic characteristics, epidemiologic history and
symptoms of the disease. The study had the approval of
the ethics committee of Hospital S João.
Parasitological diagnosis was done by thin smear and
light microscopic observation; parasitaemia quantifica-
tion was done whenever possible. Daily smears were
done until the Plasmodium smear became negative.
Since 2000, a immunochromatographic assay for the
qualitative detection of Plasmodium antigens were also
used at the emergency department (Malaria Now-
Binax
®). Clinical and laboratory parameters were ana-
lysed in order to determine which of them were asso-
ciated with ICU mortality. To evaluate severity at the
ICU admission, the Simplified Acute Physiology Score II
(SAPS II) was applied.
The degree of immunity to malaria was estimated as
follows: a) people who had been living in an endemic
area for at least two years (emigrant) at the time of the
diagnosis were presumed semi-immune, as well as adult
migrant Africans that come to Portugal to visit friends
or relatives; b) Europeans who travelled occasionally to
endemic areas were considered non- immune. WHO’s
definition for severe malaria was applied and major and
minor indicators considered according to the definitions
presented in Table 1. The number of severity criteria
was quantified and analysed.
Two prognostic scores of malaria were applied: (1)
Malaria Prediction Score (MPS) determined by: 2.13 +
0.02 × (age) + 0.25 × (creatinine) - 0.24 × (haemoglobin)
+ 3.05 (malaria cerebral criteria) + 0.8 (presence of
pregnancy) + 0.8 (ventilated) (where age = age in years;
creatinine is in mg/dl, haemoglobin in g/dl; presence of
pregnancy, cerebral malaria or ventilatory support, when
present = 1, when absent = 0) [20].; (2) Malaria Score
for Adults (MSA) was applied to all but three children
and the score was determined by: 1 (severe anaemia) +
2 (acute renal failure) + 3 (respiratory distress) + 4 (cer-
ebral malaria). The MSA ranges from 0 to 10 [20].
Variables’ definitions were: severe anaemia (Hgb < 5
g/dL), thrombocytopaenia (platelets < than 100 x10
5/
uL); acute respiratory distress syndrome (ARDS) (acute
respiratory failure defined by an acute hypoxaemia with
the ratio of the partial pressure of oxygen in the
patients’ arterial blood (PaO2) to the fraction of oxygen
in the inspired air (FIO2)( P a O 2/FIO2 ratio), less than
200 after exclusion of cardiogenic pulmonary oedema by
clinical criteria or by a pulmonary capillary wedge pres-
sure (PCWP) < 18 mm Hg in patients with a pulmonary
artery (Swan-Ganz catheter); cerebral malaria (unrousa-
ble coma), acute renal failure (ARF) (creatinine > 3 mg/
dl or urine output < 400 mL/day in adults), liver dys-
function (ALT at least two times the normal value IU/
mL), hyperbilirubinaemia (bilirubin value > 2.5 mg/dL),
hyponatraemia (Na < 125 mEq/mL), acidaemia (pH <
7.25), and hypoglycaemia (blood glucose < 40 mg/dL).
Community-acquired co-infection was defined as any
infection diagnosed within the first two days of hospita-
lization. Infections occurring later than this were consid-
ered nosocomial. ICU admission criteria other than high
parasitaemia were any cerebral dysfunction (GCS < 12),
haemodynamic instability (SBP < 80 mmHg), respiratory
distress (respiratory rate > 20/min or pCO2 < 32
mmHg), jaundice (bilirubine > 2.5 mg/dl) or renal dys-
function (oliguria or creatinine > 3 mg/dl).
Before 1992, the only available treatment for malaria
was oral triple therapy (quinine sulphate plus pyrimetha-
mine plus sulphadiazine), whereas after 1992, intrave-
nous quinine dihydrochloride plus clindamycin or
doxycycline has been chosen for the treatment of severe
cases of malaria. Artemisinin derivatives are not yet
available in Portugal. Treatment support includes: blood
products to treat severe anaemia and coagulation disor-
ders, intravenous glucose for hypoglycaemia, acetamino-
phen for hyperpyrexia, if moderate hypoxaemia oxygen
by facial mask, antibiotics for bacterial co-infection; hae-
modynamic and life support according to SSC guidelines
since 2005 [21].
Endotracheal intubation and ventilatory support would
be done if the patient had respiratory failure or neurolo-
gic dysfunction, needing airway protection; if acute oli-
guric renal failure or severe metabolic acidosis and/or
severe electrolytic imbalance were present, renal sup-
port, usually a continuous technique, would be started.
Statistical analysis was performed with Stata V12.
Descriptive statistics included frequency analysis (per-
centages) for categorical variables and median and inter-
quartile ranges (IQR) for continuous variables. The
differences in characteristics according to the outcome
were tested using Fisher exact tests or chi-squared test
for categorical variables and Wilcoxon tests for continu-
ous variables.
Results
Epidemiology
From January 1990 to May 2011, a total of 284 patients
suffering from malaria were admitted. Fifty nine (20.7%)
patients were within the criteria of severe malaria and
were admitted in the ICU-ID, a level III medical-surgical
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11. Adults’ ages varied from 20 to 71, with a median
value (IQR) of 42 (33-50), and six were older than 60;
47 (79.6%) were male.
Forty one (69%) were Portuguese emigrants working
in Africa (for a period of two or more years in 20
patients and varying from two to 34 years; for a period
of up to two years in14 patients and for a period that
has not been defined in 7); seven patients were tourists
and other seven lived in Africa and came to Portugal
(five were Africans that came to visit friends and rela-
tives and two were immigrants), and four worked in
boats that had made several stops in seaports along the
way. All but three had returned from sub-Saharan
Africa: 48 (81.3%) from former Portuguese colonies in
Africa - Angola (31), Mozambique (9), Guinea-Bissau
(7) and Sao Tome and Principe (1); the others had
returned from Senegal (2) and Gabon, Malawi, Burkina
Faso, Central African Republic, Nigeria, and Côte
d’Ivoire, one patient from each country; two other
patients had returned from Thailand and one from the
Philippines. Fifty one patients (86.4%) were white, six
black and two Asian. Malaria immune status was evalu-
ated in 54 (91.5%) patients: 25 (46.3%) were non-
immune and 29 (53.7%) semi-immune, according to the
defined criteria. Chemoprophylaxis was prescribed to 14
(23.7%) patients, but discontinued or not taken properly,
except from one patient with cerebral malaria that was
on mefloquine chemoprophylaxis.
Co-morbidities were present in 15 (25.4%) patients:
alcoholic hepatic disease, diabetes mellitus and ischemic
cardiac disease in five patients; sickle cell anaemia,
nephrolithiasis, Still disease and hepatitis C were
observed in one patient each. One had been bone mar-
row transplanted seven years before and was asympto-
matic, with no immunomodulatory therapy. An HIV
primary infection was diagnosed simultaneously with
malaria in one patient, being all other patients HIV
negative. Some patients presented more than one co-
morbidity.
Clinical features
The diagnosis was made between the day of return from
the endemic area up to the 47th day in 54 patients; in
one patient, diagnosis was done on the 120th day after
leaving Angola, where he had been for 16 consecutive
months; in other four patients, the gap was impossible
to determine.
Symptoms, namely fever before admission, varied from
one day to three weeks, the median (IQR) duration
being more than seven days in 44% of the patients. All
patients had fever. Other complaints include chills in 49
(83.0%) patients, headache in 47 (79.6%), myalgia in 45
(76.2%), vomiting in 27 (45.7%), diarrhoea in 21 (35.6%)
and cough in 13 (22.0%); clinical deterioration with cer-
ebral dysfunction (Glasgow ≤9) in 22 (37.2%) patients
and respiratory distress in 22 (37.2%) patients were
observed.
SAPS II was registered in 56 patients and the median
value (IQR) was 33 (24-46). Malaria diagnosis was estab-
lished by positive smears for asexual P. falciparum
forms. In 48 (81.3%) patients, parasitaemia quantifica-
tion was ≥ 2% and varied from 2-90%, with a median
(IQR) of 15 (9-30). Parasitaemia was considered high
but was not quantified in 13 (22%) patients. The immu-
nochromatographic assay in whole blood for the qualita-
tive detection of Plasmodium antigens, used at
emergency department, was positive in all the samples
tested.
The most common analytic changes observed in these
patients were: thrombocytopaenia in 54 (91.5%) patients
associated with DIC in seven (11.8%) and bleeding dis-
orders in another six, hyponatraemia in 34 (57.6%)
patients, acute renal failure in 31 (52.5%) patients, being
oliguric in 18 (30.5%) of them and liver dysfunction in
27 (45.7%) patients. None of the patients presented
severe anaemia according to the WHO criteria but,
despite transfusions received, 14 patients had haemoglo-
b i nl e s st h a n8g / d Lw i t ht h em i n i m u mv a l u eo f5 . 1g /
dL, being the haemoglobin IQR of 10.1 (8.0-12.6).
The criteria for severe malaria were: hyperparasitaemia
in 46 (77.9%) patients, renal failure in 31 (52.5%), shock
in 29 (49.1%), hyperbilirrubinaemia in 27 (45.7%), acid-
aemia in 23 (38.9%), pulmonary oedema or ARDS in 22
(37.2%) patients (Figure 1), cerebral dysfunction in 22
(37.2%), 11 of whom in unresponsive coma (Figure 2),
hypoglycaemia in 18 (30.5%), and haemorrhagic events
or DIC in 13 (22.0%) patients.
Considering the major WHO criteria of severe
malaria, 29 (49.1%) patients presented five or more
dysfunctions.
Anti-malarial treatment
Forty one (69.5%) patients were treated with quinine
dihydrochloride, with a 20 mg/Kg loading dose followed
by 10 mg/Kg tid, in a four-hour infusion associated with
endovenous clindamycine. The other 18 patients (30.5%)
were treated with oral quinine sulphate associated with
doxycycline or pyrimethamine plus sulphadiazine in the
first period of the study. Blood smears became negative
for Plasmodium from the second to eighth day of treat-
ment, except in a patient whose parasitaemia was 90%
and who died with positive smears in the second day
after admission.
Critical care management
All patients admitted to the ICU were close monitored
and had treatment support according to the
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red cells whenever haemoglobin was lower than 7.5 g/
dL, associated with platelets and fresh frozen plasma in
patients with bleeding disorders; blood products were
also given before an invasive technique whenever plate-
lets were lower than 50 × 10
5/uL or if coagulopathy was
present. Fluids were administered to correct
hypovolaemia monitored by central venous pressure,
mean arterial pressure and urinary output. Even so, 29
(49.1%) patients needed vasopressor support, with nora-
drenaline or dopamine or both. Ventilatory support was
needed in 22 (37.3%) patients, for a period varying from
two to 74 days (median 10 days). Two patients with
severe ARDS with refractory hypoxaemia had been put
 
Figure 1 X-ray: bilateral pulmonary infiltrates (ARDS).
Figure 2 CT- scan: cerebral swelling in intracranial hypertension (Cerebral malaria).
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(ECMO). In one of the patients, ECMO was completely
successful and the patient is now doing well, without
significant respiratory sequels; the other patient died on
ICU in refractory shock. Eight (13.6%) patients required
renal replacement therapy. Six patients had upper gas-
trointestinal bleeding and did an endoscopy for further
study. All patients began enteric nutrition in the first 48
hours, if not contraindicated. Glycaemia control was
monitored, being hypoglycaemia registered and treated
in 18 patients (30.5%).
Bacterial co-infections
Other simultaneous infections occurred in some
patients. Thirteen (22.0%) patients had pneumonia: in
two of them, pneumonia was considered community-
acquired; Pneumococcus and Klebsiella spp. were iso-
lated from the tracheal aspirate, in each patient. In the
remaining 11 cases, pneumonia was nosocomial and,
apart from one isolate (an MDR Pseudomonas aerugi-
nosa), no agent was identified; six of these patients were
ventilator associated pneumonia. All patients but one
recovered.
Another seven (11.9%) patients developed acute acal-
coulous cholecystitis, which was managed with medical
treatment in five and, in the other two, a percutaneous
drainage was done, with a favourable evolution in all of
them. Two (3.3%) patients had nosocomial central
venous catheter-associated sepsis, having Acinetobacter
baumanni been identified (from central catheter and
peripheral venipuncture) in one patient and Pseudomo-
nas aeruginosa MDR in the other; both were treated
with antibiotics and had a favourable outcome.
Outcome
The UCI stay ranged from one to 81 days, being the
average (IQR) four days (two to twelve) in survivors and
eight days (three to twenty seven) in the patients that
died (p = 0.185). All patients who came out alive from
the ICU were discharged from the hospital.
In two of them, an acute disseminated encephalomyelitis
(ADEM) was diagnosed based on neurologic dysfunction
and cerebral resonance magnetic image; both had a
favourable outcome. All patients were also evaluated after
hospital discharge for follow-up of residual dysfunctions
and no other sequelae were detected; in those whose rapid
malaria test had been consistent with coinfection with P
vivax, primaquine was prescribed after excluding Glucose-
6-Phosphate Dehydrogenase deficiency.
The global case fatality rate of the infectious diseases
department was 3.1%, but the ICU fatality rate was
15.2% (nine patients). Eight were workers: seven
returned from Angola, one from Thailand and the 9th
was a tourist who returned from Mozambique. Death
occurred between the second and 28th day. In all but
three patients death occurred in the acute phase of the
illness. One of them was a male nurse who, despite
compliance to mefloquine chemoprophylaxis, had
malaria with 30% of parasitaemia; he was conscious
when he was admitted but had a rapid neurologic dete-
rioration in some hours with severe intracranial hyper-
tension and an irreversible brain swelling on cerebral
computerized tomography image, with brain death in
the first 24 hours. In the other three patients, who died
later on, death was related to ARDS complications.
Statistical analysis
The variables associated with death (Table 2) were SAPS
II (average: 68 vs.29; p < 0.001), cerebral malaria (44.4%
vs 14.6%; p = 0.019), acute renal failure (88.9-% vs
46.0%; p = 0.027), respiratory failure (88.9% vs 29.2%; p
< 0.001), hypoglycaemia (77.8% vs 22.4%; p = 0.002),
DIC or spontaneous bleeding (62.5% vs 13.6%; p =
0.007), and acidaemia or acidosis (100% vs 29.2%; p <
0.001). Shock (77.8 vs 44.9; p = 0.08) and hyperbilirubi-
naemia (77.8% vs 40.4%; p = 0.066), although more fre-
quent in patients who died, did not reach statistical
significance. The duration of the symptoms before
admission has no statistical significance when consider-
ing the risk of death (p = 0.82), but the same was not
true when we analysed the time since the patients’ arri-
val from the endemic area to diagnosis, which was sta-
tistically associated with a worse prognosis (p = 0.02).
The number of organ dysfunctions as described in
septic shock was correlated with prognosis and this is
well documented by the presence of more than four
WHO major criteria of severe falciparum malaria and
the risk of death (p < 0.001). Renal replacement (88.9%
vs 46.0%; p = 0.027) and mechanical ventilation (88.8%
vs 28.0%; p < 0.001) were also significantly more fre-
quent in those patients who died. The median (IQR)
duration of the ICU stay increased, but without reaching
statistical significance in the nine patients who died (3-
27) vs 4 (2-13); p = 0.575).
The MPS ranged from 1.78-5.20 (median, IQR: 1.8;
0.31-3.0) and the MSA from 3-9 (median; IQR: 2; 0-5).
Comparing the median value of the two prognostic
scores, both were good predictors of death in this
cohort (Table 2). When the four scores were compared,
MPS (AUC 0.77; IC95% 0.64-0.90), MSA (0.84; IC95%
0.70-0.98), SAPS II (0.90; IC95% 0.81-0.99) and WHO
score (0.91; IC95%0.82-1.0), based on the area under the
ROC curve, the best death predictors were SAPS II and
the WHO scores (Figure 3).
Discussion
In this retrospective study 59 consecutive patients with
severe malaria admitted in a Portuguese infectious
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Obviously, the longer the period, the greater the impact
of lost data, but the sample did not change over time
and it includes mostly adult white males, middle-aged,
travelling for work reasons. Malaria is a complex disease
and it is well known that the higher the parasitaemia
the greater the systemic inflammatory response and the
production of cytokines and so, a major risk of organ
dysfunctions, but some aspects concerning severe forms
need to be clarified [21-23]. The WHO has redefined
the criteria of severe malaria and pointed out a list of
complications, but prognostic importance of each com-
plication has not been well established. So, parameters
usually associated with poor prognosis should not be
forgotten and the patients’ monitoring according to
their presence or possibility, including the admission to
an ICU [22].
In this paper, the ICU admission was based on the
presence of at least a life-threatening organ dysfunction,
haemodynamic instability, as well as high parasitaemia,
which often precedes clinical deterioration. Delay in
diagnosis of malaria has been associated with a worse
prognosis [24,25], but this was not found in this review,
where 49% of the patients had the symptoms for more
than a week before diagnosis, without any correlation
with a worse prognosis. It is difficult to explain the rea-
sons why. The validity of the variable (duration of symp-
toms) may be questioned because the time since arrival
Table 2 Comparison of different parameters between severe malaria cases who survived and those who died in ICU
Survivors
(n = 50)
Non-survivors
(n = 9)
P*
Age [median IQR] 42 (33-49) 45 (33-57) 0,353
Male gender [n (%)] 38 (76.0) 9 (100) 0.161
Duration of symptoms [median IQR] 7 (4-9) 6 (4-8) 0.828
Time since arrival to diagnosis [median IQR] 8 (6-15) 16 (10-20) 0.027
Non-immune (vs semi-immune) status [n (%)] 24/46(52.2) 5/8 (62.5) 0.711
Parasitaemia [n (%)] 15 (30.3) 2 (22.2) 0.252
≤10 19 (38.0) 3 (33.3)
11-50 4 (8.0) 3 (33.3)
> 50 12 (24.4) 1 (11.1)
Non quantified
SAPS II [median (IQR)] 28.5 (21.5-37) 68 (47-73) < 0.001
Glasgow coma scale [n (%)] ≥13 33 (68.8) (22.2) 0.019
10-12 (rousable coma) 8 (16.7) 3 (33.3)
≤ 9 (unrousable coma) 7 (14.6) 4 (44.4)
Haemoglobin (mg/dL) [median (IQR)] 9.5 (8.0-12.6) 10.4 (8.3-12.2) 0.618
Renal failure [n (%)] 23 (46.0) 8 (88.9) 0.027
Pulmonary oedema/ARDS [n (%)] 14 (29.2) 8 (88.9) < 0.001
Hypoglycaemia [n (%)] 11 (22.4) 7 (77.8) 0.002
Circulatory collapse, shock [n (%)] 22 (44.9) 7 (77.8) 0.080
Abnormal bleeding/DIC [n (%)] 6 (13.6) 5 (62.5) 0.007
Acidaemia/acidosis [n (%)] 14 (29.8) 9 (100) < 0.001
WHO major criteria of severe malaria ≥ 5 [n (%)] 20 (40.0) 9 (100) < 0.001
Malaria Prediction Score (MPS)
ref [median (IQR)] 1.78 (0.38-4.53) 4.68 (4.21-5.20) 0.008
Malaria Score for Adults (MAS)
ref [median (IQR)] 3 (1-7) 9 (6-10) 0.001
Length of stay in ICU [median (IQR)] 4 (2-12) 8 (3-27) 0.185
* c
2 test or Fisher exact test for categorical variables, Wilcoxon test for continuous variables. IQR = interquartile ranges
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Figure 3 ROC curve of four scores death predictors.
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death. A delay in diagnosis can be caused by patient
ignorance about the potential severity of malaria, auto
medication for fever with antipyretics before seeking
medical attention or the doctor’s delay in considering
the diagnosis, only overcome with proper training and
experience. In this review, the case fatality rate was
15.2% (nine patients) and factors statistically associated
with death were time since arrival to diagnosis (p =
0.027), SAPS II score (p < 0.001), cerebral malaria (p =
0.019), acute renal failure (p < 0.001), ARDS (p < 0.001),
hypoglycaemia (p = 0.02), DIC or spontaneous bleeding
(p = 0.007) and acidaemia (p < 0.001) (Table 2); the
need for renal replacement (p = 0.027) and invasive ven-
tilation (p = 0.027) was significantly more frequent in
those who died. These data are in agreement with litera-
ture review, where the fatality rate is higher in cerebral
malaria and acute respiratory distress syndrome (ARDS).
Two of the patients were put on ECMO, used as a res-
cue therapy [26-28]. They had been working in Angola
and Mozambique for some years, had parasitaemia 2%
and 3% respectively and severe ARDS and multiorganic
d y s f u n c t i o n .O n eo ft h e ms u r v i v e da n dr e c o v e r e dw i t h -
out respiratory sequelae, the other died in refractory
shock. These cases show the importance of a clinical
surveillance of all patients, because the evolution is
sometimes unfavourable in cases that initially seemed
benign. The patient on mefloquine chemoprophylaxis
that died had a parasitaemia of 30% and a fulminant
evolution. Unfortunately he was not autopsied and it
was impossible to investigate if it was a problem of
resistance to mefloquine.
T h en u m b e ro fo r g a nd y s f u n c t i o n sm a yb ed i r e c t l y
correlated with mortality as was observed in this cohort,
where the presence of more than four WHO major cri-
teria for severe falciparum malaria significantly
increased the risk of death (100% vs 40%; p < 0.001)
[11,29,30].
Unexpectedly, age, duration of symptoms, immune
status, parasitaemia level, bilirubin value and the pre-
sence of shock were not statistically associated with
mortality, even though hyperbilirubinaemia and shock
were more frequent in patients who died, but diverse
results are found in different studies [31]. These results
should be interpreted with some caution because the
study covers a small number of patients over a long per-
iod of time, although this does not necessarily explain
the discrepancies between this and other studies. Pre-
vious papers reporting malaria parameters associated
with mortality, mainly retrospective, have different aims
and different degrees of severity and only a few of them
take ICU cohorts into consideration [12,13,32,33]. This
i st h ec a s eo fas t u d yr e p o r t e di n2 0 0 3f r o maF r e n c h
group that evaluated 188 ICU patients with imported
falciparum malaria over a 12-year period [10] with an
overall mortality rate of 5.3% but, in most severe
patients, the mortality rate was 11%. Factors associated
with death were SAPS II, shock, acidosis, coma, pul-
monary oedema and coagulation disorders.
No predictive malaria score system had been used as
routine. Two malaria prognostic scores (MSA and MPS)
used in this cohort were good death predictors [20].
When the four scores applied, SAPS II, MPS, MSA and
WHO score were compared, SAPS II and the WHO
score were the most sensitive to predict death (Figure
1).
Patients with severe forms of malaria are highly sus-
ceptible to bacterial infections and WHO recommends
concomitant antibiotic therapy. In this review, some
infections were documented: 13 patients had pneumo-
nia, two of them community-acquired and 11 nosoco-
mial, seven had acute acalculous cholecystitis and, in
another two patients, central venous catheter-associated
sepsis occurred. Although malaria acute acalculous cho-
lecystitis is rarely reported, seven cases (11.9%) were
found in this cohort [34,35].
T h eH I Vp r i m a r yi n f e c t i o nw a sc o n s i d e r e da st h e
patient has been tested six months before, when he was
treated for a cellulitis, having on that date a negative
test for the HIV virus. The patient had a favourable evo-
lution without concomitant antiretroviral therapy. There
is no consensus about severity or complicated malaria in
HIV co-infected adults but the fact that fever is a com-
mon symptom to both diseases can delay both diagnoses
[7].
Post-malaria neurological syndrome, another rare
complication, was reported in two patients who recov-
ered completely. This neurological syndrome has been
defined as the acute neuropsychiatric manifestation in
patients recently recovered from malaria [36].
The prevention of malaria is essential with easy inter-
ventions such as different barrier methods and chemo-
prophylaxis whenever justified. Pre-travel advice and
general practitians should stress prevention measures.
Although the study does not point out that a delay in
diagnosis is directly connected with a worsening of
malaria, people at risk should be informed about the
malaria symptoms, allowing an early diagnosis and
treatment.
Although anti-malarial drug medication is the only
intervention of proven efficacy to treat severe malaria, it
is very important to monitor and treat severe forms
with organic dysfunctions in ICU [37].
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